February 17, 2015 | According to reports, the Chinese pharmaceutical company Fosun Pharma is interested in acquiring Israeli aesthetic medicine company Lumenis. Foshun Pharma, which owns one of Lumenis’ Israeli competitors Alma Lasers, has apparently begun to approach shareholders regarding a possible deal. Lumenis is traded at a market-cap of $380 million and is run by Tzipi Ozer-Armon.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments